PATENT CLAIM ANALYSIS

Application Number: 15959379
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-12
Patent Classification: ["514", "04400R"]

Abstract:
The invention relates to the use of a pharmaceutical composition containing nicotinamide (NAM) and/or pyruvate as a neuroprotective medicament or gene therapy in the treatment of neurodegenerative disorders, in particular axon degeneration of neuronal tissue in ocular-related neurodegeneration diseases including glaucoma.

Claim (Index 10):
The method of  claim 9 , wherein said polynucleotide is in a viral vector.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 91.0
- Lexical Diversity: 1.15385
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['11144358', '14511701', '14434573', '15632106', '12563483']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7678595242176998
- 35 USC 102 Novelty (BERT): 0.5181297772294359
- Combined Prediction Score: 0.7428865495188733
- Mean Citation Score: 271.268122
- Max Citation Score: 301.51733
- Similarity Product: 211.23587909044448

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test